Skip to main content
Log in

Tumor idiotype vaccines

VIII. Analysis of protective idiotype in sera and hybridomas derived from tumor-bearing mice with long-term survival

  • Original Articles
  • Idiotype, Hybridoma, Tumor, T Cells
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

In this study, the contribution of idiotype-positive antitumor antibodies (anti-Id) in protective tumor immunity was investigated. We have previously shown that among various anti-Id generated and typed as the internal-image Ab2 of the tumor-associated antibody (TAA) gp52, only 2F10 antibody induces protective immunity. Increase of the 2F10 idiotope in sera of tumor-bearing mice correlated with long-term survival, while in mice with short survival the circulating 2F10 idiotype decreased. 2F10+ Ig were purified from sera of tumor-bearing mice with longterm survival and the amount of 2F10+ anti-TAA antibodies was determined. Only about 3% of 2F10+ antibodies are 2F10+ anti-TAA+. Hybridomas were generated from a 2F10 high mouse with spontaneous tumor regression. Only 2 out of 52 tumor-specific hybridomas were 2F10+. These results suggest that the protective effect induced by 2F10 vaccination may not be directly mediated by 2F10+ antibodies but indirectly through the stimulation of a 2F10-specific cellular immune response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mittelman A, Chen ZJ, Yang H, Wong GY, Ferrone S (1992) Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma. Proc Natl Acad Sci USA 89: 466

    PubMed  Google Scholar 

  2. Herlyn D, Wettendorf M, Schmoll E, Ilopoulos D, Schedel I, Dreikhausen U, Raab R, Ross AH, Jaksche H, Scriba M, Koprowski H (1987) Anti-idiotype immunization of cancer patients: modulation of the immune response. Proc Natl Acad Sci USA 84: 8055

    PubMed  Google Scholar 

  3. Raychaudhuri S, Fuji H, Kohler H (1986) Tumor specific idiotype vaccines. I. Generation and characterization of internal image tumor antigens. J Immunol 137: 1743

    PubMed  Google Scholar 

  4. Bhattacharya-Chatterjee M, Pride MW, Seon BK, Kohler H (1987) Idiotype vaccines against human T cell acute lymphoblastic leukemia. I. Generation and characterization of biologically-active monoclonal anti-idiotopes. J Immunol 139: 1354

    PubMed  Google Scholar 

  5. Bhattacharya-Chatterjee M, Mukerjee S, Biddle W, Foon KA, Kohler H (1990) Syngeneic monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen. J Immunol 145: 2758

    PubMed  Google Scholar 

  6. Chattopadhyay P, Sneed D, Rosenberg J, Starkey J, Robertson N, Leonard J, Raychaudhuri S (1991) Monoclonal anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen: generation and characterization anti-idiotype antibodies. Cancer Res 51: 3183

    PubMed  Google Scholar 

  7. Raychaudhuri S, Saeki Y, Chen J-J, Iribe H, Kohler H (1987) Tumorspecific idiotype vaccines. II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2beta). J Immunol 139: 271

    PubMed  Google Scholar 

  8. Raychaudhuri S, Kang C-Y, Kaveri S-V, Kieber-Emmons T., Kohler H (1990) Tumor idiotypic vaccines. VII. Analysis and correlation of structural, idiotypic and biological properties of protective and non-protective Ab2s. J Immunol 145: 760

    PubMed  Google Scholar 

  9. Raychaudhuri S, Saeki Y, Chen J-J, Kohler H (1987) Tumor specific idiotype vaccine. III. Indication of T helper cells by anti-idiotype and tumor cells. J Immunol 139: 2096

    PubMed  Google Scholar 

  10. Saeki Y, Chen J-J, Shi L, Kohler H (1989) Characterization of “regulatory” idiotype-specific T cell clones to a monoclonal anti-idiotypic antibody mimicking a tumor-associated antigen (TAA) J Immunol 142: 1046

    PubMed  Google Scholar 

  11. Chen J-J, Saeki Y, Kohler H (1990) Idiotype matching: Correlation of expression of protective idiotype in sera with survival of tumor mice. J Immunol 144: 759

    PubMed  Google Scholar 

  12. Rapp L, Fuji H (1989) Differential antigenic expression of the DBA/2 lymphoma L 1210 and its sublines: cross reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies. Cancer Res 43: 2592

    Google Scholar 

  13. Fuji H, Iribe H (1986) Clonal variation in tumor genicity of L 1210 lymphoma cells: nontumorigenic variants with an enhanced expression of tumor-associated antigens and la antigens. Cancer Res 46: 5541

    PubMed  Google Scholar 

  14. Wittner MK, Bach MA, Kohler H (1982) Immune response to phosphorylcholine. IX. Characterization of hybridoma anti-TEPC-15 antibodies. J Immunol 128: 595

    PubMed  Google Scholar 

  15. Kohler H, Raychaudhuri S, Chen J-J (1992) Tumor idiotype vaccine: correlation of the idiotype-recognizing T cell repertoire with tumor growth. Vaccine Res 1: 33

    Google Scholar 

  16. Lanzavecchia A, Abrignani S, Scheidegger D, Obrist R, Dorken B, Moldenhauer G (1988) Antibodies as antigens: the use of mouse monoclonal antibodies to focus human T cells againts selected targets. J Exp Med 167: 345

    PubMed  Google Scholar 

  17. Saeki Y, Chen J-J, Shi L, Kohler H (1989) Idiotypic intermolecular help: Induction of tumor specific antibodies by monoclonal anti-idiotypic antibody with the help of Fe-specific T helper clones. J Immunol 142: 2629

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by a grant from N.I.H. no. CA51434

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, JJ., Kohler, H. Tumor idiotype vaccines. Cancer Immunol Immunother 37, 373–377 (1993). https://doi.org/10.1007/BF01526793

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01526793

Key words

Navigation